Serologic diagnosis of chlamydial and Mycoplasma pneumoniae infections;Limites et perspectives du diagnostic sérologique à l'ère de l'amplification génique in vitro: Infections génitales à Chlamydia trachomatis et infections respiratoires à Chlamydia pneumoniae et Mycoplasma pneumoniae

Annales de Biologie Clinique

Volumn 64, Issue 5, 2006, Pages 409-419

  De Barbeyrac, B ^a   Obeniche, F ^a   Ratsima, E ^a   Labrouche, S ^a   Morate C ^a   Renaudin, H ^a   Pereyre, S ^a   Bebear C M ^a   Bebear C ^a  

^a BORDEAUX UNIVERSITY HOSPITAL   (France)

Author keywords

Chlamydia pneumoniae; Chlamydia trachomatis; Mycoplasma pneumoniae; Serodiagnosis

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ADOLESCENT; ADULT; BACTERIAL INFECTION; BLOOD; CHILD; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; COMPARATIVE STUDY; COMPLEMENT FIXATION TEST; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMAN; IMMUNOLOGY; MYCOPLASMA PNEUMONIA; MYCOPLASMA PNEUMONIAE; PRESCHOOL CHILD; REVIEW; SENSITIVITY AND SPECIFICITY; SEROLOGY;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; CHLAMYDOPHILA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; COMPLEMENT FIXATION TESTS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MYCOPLASMA PNEUMONIAE; PNEUMONIA, MYCOPLASMA; SENSITIVITY AND SPECIFICITY; SEROLOGIC TESTS;

CHLAMYDIA TRACHOMATIS; CHLAMYDOPHILA PNEUMONIAE; MYCOPLASMA PNEUMONIAE;

EID: 33750366817     PISSN: 00033898     EISSN: None     Source Type: Journal    
DOI: 10.1684/abc.2006.0002     Document Type: Review

References (19)

1. Barbeyrac de B, Bebear C. Chlamydial pathogenesis : diagnostic and therapeutic consequences. Arch Pediatr 2005 ; 12 (Suppl. 1) : S26-S31.
2. Clad A, Freidank HM, Kunze M, et al. Detection of seroconversion and persistence of Chlamydia trachomatis antibodies in five different serological tests. Eur J Clin Microbiol Infect Dis 2000 ; 19 : 932-7.
3. Persson K. The role of serology, antibiotic susceptibility testing and serovar determination in genital chlamydial infections. Best Pract Res Cl Ob 2002 ; 16 : 801-14.
4. Eckert LO, Hawes SE, Wolner-Hanssen P, et al. Prevalence and correlates of antibody to chlamydial heat shock protein in women attending sexually transmitted disease clinics and women with confirmed pelvic inflammatory disease. J Infect Dis 1997 ; 175 : 1453-8.
5. Peeling RW, Kimani J, Plummer F, et al. Antibody to chlamydial hsp60 predicts an increased risk for chlamydial pelvic inflammatory disease. J Infect Dis 1997 ; 175 : 1153-8.
6. Barbeyrac de B, Allery A, Marazanof V, Bébéar C. Chlamydia : apport de la biologie moléculaire face aux techniques sérologiques. Feuill Biol 1999 ; 231 : 21-7.
7. Mouton JW, Peeters MF, van Rijssort Vos JH, Verkooyen RP. Tubal factor pathology caused by Chlamydia trachomatis : the role of serology. Int J STD AIDS 2002 ; 13 (Suppl. 2) : 26-9.
8. Ginevra C, Barranger C, Ros A, et al. Development and evaluation of Chlamylege, a new commercial test allowing simultaneous detection and identification of Legionella, Chlamydophila pneumoniae, and Mycoplasma pneumoniae in clinical respiratory specimens by multiplex PCR. J Clin Microbiol 2005 ; 43 : 3247-54.
9. Wang S. The microimmunofluorescence test for Chlamydia pneumoniae infection : technique and interpretation. J Infect Dis 2000 ; 181 (Suppl. 3) : S421-S425.
10. Hermann C, Gueinzius K, Oehme A, von Aulock S, Straube E, Hartung T. Comparison of quantitative and semiquantitative enzyme-linked immunosorbent assays for immunoglobulin G against Chlamydophila pneumoniae to a microimmunofluorescence test for use with patients with respiratory tract infections. J Clin Microbiol 2004 ; 42 : 2476-9.
11. Tompkins LS, Schachter J, Boman J, et al. Collaborative multidisciplinary workshop report : detection, culture, serology, and antimicrobial susceptibility testing of Chlamydia pneumoniae. J Infect Dis 2000 ; 181 (Suppl. 3) : S460-S461.
12. Peeling RW, Wang SP, Grayston JT, et al. Chlamydia pneumoniae serology : interlaboratory variation in microimmunofluorescence assay results. J Infect Dis 2000 ; 181 (Suppl. 3) : S426-S429.
13. Dowell SF, Peeling RW, Boman J, et al. Standardizing Chlamydia pneumoniae assays : recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada). Clin Infect Dis 2001 ; 33 : 492-503.
14. Tuuminen T, Palomaki P, Paavonen J. The use of serologic tests for the diagnosis of chlamydial infections. J Microbiol Meth 2000 ; 42 : 265-79.
15. Waites KB, Talkington DF. Mycoplasma pneumoniae and its role as a human pathogen. Clin Microbiol Rev 2004 ; 17 : 697-728.
16. Bébéar C. Les mycoplasmes : aspects biologiques, diagnostiques et thérapeutiques. In : Bébéar C, ed. Mycoplasmes et Chlamydiae. Paris : Elsevier, 2002 : 4-19.
17. Waites K, Bébéar C, Robertson J, Talkington D, Kenny G. Cumitech 34, Laboratory diagnosis of mycoplasmal infections. In : Nolte FS, ed. Washington : American Society for Microbiology, 2001.
18. Beersma MF, Dirven K, van Dam AP, Templeton KE, Claas EC, Goossens H. Evaluation of 12 commercial tests and the complement fixation test for Mycoplasma pneumoniae-specific immunoglobulin G (IgG) and IgM antibodies, with PCR used as the gold standard. J Clin Microbiol 2005 ; 43 : 2277-85.
19. Petitjean J, Vabret A, Gouarin S, Freymuth F. Evaluation of four commercial immunoglobulin G (IgG)- and IgM-specific enzyme immunoassays for diagnosis of Mycoplasma pneumoniae infections. J Clin Microbiol 2002 ; 40 : 165-71.